title: Homocysteine is unlikely to be associated with the risk of thromboembolic complications in atrial fibrillation.
authors.forename: Sunil
authors.initials: S
authors.lastname: Nadar
authors.forename: Andrew
authors.initials: A
authors.lastname: Blann
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
mesh_terms: D000328:Adult; D000367:Age Factors; D000368:Aged; D001281:Atrial Fibrillation / Q000097:blood / Q000150:complications*; D005260:Female; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D020138:Hyperhomocysteinemia / Q000150:complications / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D012306:Risk; D013923:Thromboembolism / Q000453:epidemiology* / Q000209:etiology; D019851:Thrombophilia / Q000097:blood* / Q000209:etiology; D018487:Ventricular Dysfunction, Left / Q000150:complications
chemical_list: D006710:Homocysteine